Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN2690 (Tavaborole) PK and Efficacy in Onychomycosis
NCT00680160Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tavaborole in onychomycosis, sponsored by Pfizer. Started Apr 2006; status: completed.
02
Drugs
tavaborole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00680160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680160.